Nuwellis Inc. stock surges after crossing above key SMA
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 15 Jan 26
Source: Coinmarketcap
Nuwellis Inc. shares rose significantly, crossing above the 5-day SMA, reflecting strong investor interest.
The stock's movement comes amid broad market strength, with the Nasdaq-100 and S&P 500 both showing gains. This positive market environment has likely contributed to the upward momentum in Nuwellis shares.
Investors are optimistic about Nuwellis' future prospects, and the recent price action may attract further attention from traders looking for growth opportunities.
Analyst Views on NUWE
Wall Street analysts forecast NUWE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NUWE is 3.90 USD with a low forecast of 3.90 USD and a high forecast of 3.90 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
0 Buy
1 Hold
0 Sell
Hold
Current: 3.860
Low
3.90
Averages
3.90
High
3.90
Current: 3.860
Low
3.90
Averages
3.90
High
3.90
About NUWE
Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
